e-learning
resources
Virtual 2021
05.09.2021
COVID-19 and obstructive diseases: risk factors, management and long-term effects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of COVID-19 on COPD and Asthma admissions and the pandemic from a patient’s perspective
D. Sykes (Hull, United Kingdom), S. Faruqi (Hull, United Kingdom), L. Holdsworth (Hull, United Kingdom), M. Crooks (Hull, United Kingdom)
Source:
Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Session:
COVID-19 and obstructive diseases: risk factors, management and long-term effects
Session type:
E-poster
Number:
958
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Sykes (Hull, United Kingdom), S. Faruqi (Hull, United Kingdom), L. Holdsworth (Hull, United Kingdom), M. Crooks (Hull, United Kingdom). Impact of COVID-19 on COPD and Asthma admissions and the pandemic from a patient’s perspective. 958
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Burden of exacerbations in COPD: physician and patient perspectives
Source: Eur Respir J 2004; 24: Suppl. 48, 474s
Year: 2004
Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
Source: ERJ Open Res, 7 (3) 00242-2021; 10.1183/23120541.00242-2021
Year: 2021
Reduction in hospital admissions for Acute Exacerbations of COPD during COVID-19 pandemic
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021
Asthma admissions: Characteristics of patients admitted to a specialized respiratory hospital
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
Reduction in asthma admissions during the COVID-19 pandemic: consequence of public health measures in Singapore
Source: Eur Respir J, 57 (4) 2004493; 10.1183/13993003.04493-2020
Year: 2021
The impact of a specialist multi-disciplinary approach on burden of frequent asthma admissions
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Asthma management and control during COVID-19 pandemic
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021
Variability of hospital resources for acute care of COPD patients: the European COPD Audit
Source: Eur Respir J 2014; 43: 754-762
Year: 2014
Evaluation of multiple admissions of COPD patients: European COPD audit
Source: Annual Congress 2012 - Acute exacerbation in COPD
Year: 2012
COPD telemonitoring: Analysis of hospital admissions
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Social distancing and admissions for severe exacerbations of COPD – a nationwide study
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit
Source: Eur Respir J 2016; 47: 113-121
Year: 2016
Physician consultation and outcomes of treatment in exacerbations of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 559s
Year: 2003
Rethinking COPD Exacerbations: a global patient perspective
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Year: 2021
Trends in the asthma hospitalization rate in the Spanish pediatric population
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Are acute asthma admissions preventable with improved patient education?
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Impact of checklist proforma on discharge and follow up care of patients admitted with COPD exacerbations
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011
Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Disease management for asthma and COPD, the respiratory nurse as the corner-stone
Source: Eur Respir J 2003; 22: Suppl. 45, 512s
Year: 2003
The impact of implementing a COPD care bundle on the delivery of care to patients admitted with an acute exacerbation of COPD
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept